Six-year outcome in subjects diagnosed with attention-deficit/hyperactivity disorder as adults

被引:19
作者
Edvinsson, Dan [1 ]
Ekselius, Lisa [1 ]
机构
[1] Uppsala Univ, Uppsala Univ Hosp, Dept Neurosci, Psychiat, Uppsala, Sweden
基金
瑞典研究理事会;
关键词
ADHD; Adult; Outcome; Response; Pharmacotherapy; DEFICIT HYPERACTIVITY DISORDER; EXTENDED-RELEASE METHYLPHENIDATE; SHEEHAN DISABILITY SCALE; QUALITY-OF-LIFE; PSYCHIATRIC COMORBIDITY; GENERAL-POPULATION; DOUBLE-BLIND; AXIS-I; ADHD; METAANALYSIS;
D O I
10.1007/s00406-017-0850-6
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
There are very few studies on the long-term outcome in subjects diagnosed with ADHD as adults. The objective of the present study was to assess this and relate the outcome to whether there was current medication or not and to other potential predictors of favourable outcome. A prospective clinical cohort of adults diagnosed with ADHD according to DSM-IV criteria was followed-up on an average of 6 years after first evaluation (n = 124; mean age 42 years, 51% males). ADHD symptom trajectories were assessed as well as medication, global functioning, disability, health-related quality of life, and alcohol and drug consumption at follow-up. Ninety percent of those diagnosed were initially treated pharmacologically and half of them discontinued treatment. One-third reported remission, defined as not fulfilling any ADHD subtype and a GAF-value last year >= 70, which was not affected by comorbidity at baseline. Current medication was not associated with remission. Subjects evaluated and first diagnosed with ADHD as adults are functionally improved at follow-up 6 years later despite a high percentage of psychiatric comorbidity at baseline. Half dropped out of medication, and there was no difference in ADHD remission between subjects with on-going medication at follow-up or subjects without medication, although current medication was related to a higher degree of self-reported global improvement.
引用
收藏
页码:337 / 347
页数:11
相关论文
共 58 条
[1]  
Adler Lenard A, 2006, Ann Clin Psychiatry, V18, P145, DOI 10.1080/10401230600801077
[2]   Evaluation of the Persistence, Remission, and Emergence of Attention-Deficit/Hyperactivity Disorder in Young Adulthood [J].
Agnew-Blais, Jessica C. ;
Polanczyk, Guilherme V. ;
Danese, Andrea ;
Wertz, Jasmin ;
Moffitt, Terrie E. ;
Arseneault, Louise .
JAMA PSYCHIATRY, 2016, 73 (07) :713-720
[3]  
[Anonymous], 2008, NICE clinical guideline, V72
[4]  
[Anonymous], 2000, DIAGN STAT MAN MENT, DOI DOI 10.1176/APPI.BOOKS.9780890425787
[5]   Addressing the lack of studies in attention-deficit/hyperactivity disorder in adults [J].
Antoni Ramos-Quiroga, Josep ;
Nasillo, Viviana ;
Fernandez-Arana, Fernando ;
Casas, Miguel .
EXPERT REVIEW OF NEUROTHERAPEUTICS, 2014, 14 (05) :553-567
[6]  
Babor TF., 1989, AUDIT ALCOHOL USE DI
[7]   Mortality, ADHD, and Psychosocial Adversity in Adults With Childhood ADHD: A Prospective Study [J].
Barbaresi, William J. ;
Colligan, Robert C. ;
Weaver, Amy L. ;
Voigt, Robert G. ;
Killian, Jill M. ;
Katusic, Slavica K. .
PEDIATRICS, 2013, 131 (04) :637-644
[8]   Two-Year Outcome of Treatment With Central Stimulant Medication in Adult Attention-Deficit/Hyperactivity Disorder: A Prospective Study [J].
Bejerot, Susanne ;
Ryden, Eleonore M. ;
Arlinde, Christina M. .
JOURNAL OF CLINICAL PSYCHIATRY, 2010, 71 (12) :1590-1597
[9]   Evaluation of the Drug Use Disorders Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample [J].
Berman, AH ;
Bergman, H ;
Palmstierna, T ;
Schlyter, F .
EUROPEAN ADDICTION RESEARCH, 2005, 11 (01) :22-31
[10]   A Randomized, 3-Phase, 34-Week, Double-Blind, Long-Term Efficacy Study of Osmotic-Release Oral System-Methylphenidate in Adults With Attention-Deficit/Hyperactivity Disorder [J].
Biederman, Joseph ;
Mick, Eric ;
Surman, Craig ;
Doyle, Robert ;
Hammerness, Paul ;
Kotarski, Meghan ;
Spencer, Thomas .
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY, 2010, 30 (05) :549-553